Rocky Mountain Cancer Centers, LLP

Clinical research site in Pueblo, Colorado · 3676 PARKER BLVD STE 350, PUEBLO, CO 81008-2213 · (719) 296-6000 · Website

Part of US Oncology

As of July 2026, 7 paid clinical trials are recruiting at Rocky Mountain Cancer Centers, LLP in Pueblo, Colorado. Active studies at this site cover conditions such as Colorectal Neoplasms, Breast Cancer and Breast Neoplasms. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Rocky Mountain Cancer Centers, LLP (7)

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma

61 locations incl. Los Angeles

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07392892·Phase 2, Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for Intestinal Neoplasms

166 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

102 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for Colorectal Neoplasms

104 locations incl. Glendale

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

for Breast Cancer

134 locations incl. Daphne

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06966453·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

for Non Small Cell Lung Cancer (Squamous or Non Squamous)

9 locations incl. Daphne

Sponsor: Eikon Therapeutics

Sex: All·Age: 18+

Code: NCT07365319·Phase 2, Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Improving Care for Rural Patients With Solid Tumors

for Lung Cancer

14 locations incl. Aurora

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 99

Code: NCT04916990·Recruiting·Listed Jun 2021

Apply to this trial

More research sites in Pueblo

Saint Mary Corwin Medical Center (26 trials)
Local Institution - 007-872-B (1 trial)
Local Institution - 0520 (1 trial)
Retina Consultants of Southern Colorado (1 trial)
Rocky Mountain Cancer Center (1 trial)
Rocky Mountain Cancer Centers LLP (1 trial)
UCHealth - Parkview medical Center (1 trial)

Explore more

Paid clinical trials in Pueblo, CO · Colorado clinical trials